Home

Current Issue

Archives

Guidelines for Authors

Classified Ads

Links

Search PubMed

Subscriptions

Subscriber Registration

Guidelines for Website Users

JRheum Update Service

Contact Info

Correction

Genovese MC, Mease PJ, Thomson GTD, et al, for the M02-570 Study Group. Safety and efficacy of adalimumab in treatment of patients with psoriatic arthritis who had failed disease modifying antirheumatic drug therapy. J Rheumatol 2007;34:1040-50. Table 1. At line 7 under the side heading Medications: Use of NSAID at baseline for the Adalimumab 40 mg eow group; n (%) should be 37 (72.5) not 37 (72.6). At line 9: Use of oral corticosteroids at baseline for the Placebo group; n (%) should be 8 (16.3) not 9 (18.4). We regret the errors.